Mounjaro®
Starting from £179.99/mo
Start journey Learn moreCertain foods consistently make Mounjaro harder to tolerate and harder to work with. High-fat meals, very sugary foods, carbonated drinks and highly processed snacks are the main ones to avoid — not because they are forbidden, but because tirzepatide slows gastric emptying, and these categories amplify nausea, reflux and digestive discomfort significantly. Mounjaro (tirzepatide) is a prescription-only medicine (a dual GIP and GLP-1 receptor agonist) and what you eat alongside it shapes both how well you tolerate the injections and the results you see. The NHS tirzepatide guidance recommends following a reduced-calorie diet as part of treatment; your prescriber can tailor that advice to your situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first week or two on Mounjaro is when your digestive system is adjusting. Tirzepatide slows the rate at which your stomach empties, which is part of how it reduces appetite, but it also means food that would normally pass through in a few hours sits longer. High-fat foods sit longest of all. A greasy takeaway, a heavy cream sauce or a large portion of chips eaten in the days after an injection can produce nausea, vomiting or reflux that lasts hours.
Fried foods are the most consistent culprit reported by people on tirzepatide. Deep-fried anything (battered fish, fried chicken, pakoras, doughnuts) combines fat, volume and rapid eating in a way the slower-moving stomach simply cannot handle well. The fix is not a crash diet; it is moving those meals to smaller portions, less frequently, and avoiding them entirely on injection day and the day or two after. Choosing the right foods on Mounjaro becomes much easier once you understand this mechanism rather than following a rigid list.
Spicy food is worth noting separately. It does not cause the same fat-digestion issue, but it can aggravate reflux in people who are already experiencing some GI discomfort on the medicine. If you are prone to heartburn, spicy dishes are worth rotating out during dose increases.
One misconception worth setting aside gently: Mounjaro does not neutralise calories. Some people start treatment expecting the medicine to do all the work regardless of what they eat, and then feel stuck when results plateau. The appetite reduction is real and significant, but ultra-processed foods (crisps, biscuits, packaged pastries, sugary cereals) are specifically engineered to override satiety signals. They are calorie-dense, low in protein and fibre, and they bypass the fullness cues that tirzepatide is reinforcing.
Sugary drinks deserve particular attention. Fizzy drinks add calories with essentially no nutritional benefit, trigger bloating on a stomach that is already slower to empty, and the carbonation alone can cause uncomfortable belching and fullness. Fruit juice has the same sugar problem without the carbonation. Swapping to still water, plain sparkling water or unsweetened herbal tea makes a measurable difference in comfort, and in the space you have for protein-rich meals that actually support the treatment.
The NICE appraisal of tirzepatide recommends it alongside a reduced-calorie diet and increased physical activity; the dietary component is not a footnote. If you are curious about what you should not eat on Mounjaro in the UK context, the key is recognising which foods are working against the medicine, not just following generic clean-eating rules. If you are wondering how to handle days when appetite drops to almost nothing, eating well on Mounjaro when you are not hungry covers practical approaches.
Alcohol is not explicitly banned on tirzepatide, but the caution is real. It lowers blood sugar, which matters more when the medicine is already influencing glucose regulation. It also irritates the gastric lining (adding fuel to any nausea or reflux already present) and it disrupts the hunger and fullness signals that are supposed to be working in your favour. A single drink may feel very different to how it did before starting treatment; many people find their tolerance shifts.
Caffeine on an empty stomach is a smaller but relevant issue. Strong coffee first thing, with nothing else eaten, can worsen acid and nausea in people who are already sensitive. It is not a reason to give up coffee entirely, but having something small with it makes a practical difference for most people on the medicine.
For a fuller picture of specific foods and whether occasional treats fit in, the question about chocolate on Mounjaro is a useful illustration of how context and portion size matter more than blanket bans. Our guide to food not to eat on Mounjaro covers additional categories in detail, and is worth reading alongside the broader list of foods to approach carefully on Mounjaro. If you are already on treatment and finding digestion difficult, speaking to your prescriber is the right next step, and if you are considering starting, checking your eligibility with our team is where that conversation begins.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.